The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-3 of 3 articles
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry
Wlodarczak A,
Montorsi P,
Torzewski J,
Bennett J,
Starmer G,
Buck T,
Haude M,
Moccetti M,
Wiemer M,
Lee M,
Verheye S
May 24, 2023 | 10.4244/EIJ-D-22-01069
A new resorbable magnesium scaffold for de novo coronary lesions, the DREAMS 3G: one-year results of the BIOMAG-1 first-in-human study
Haude M,
Wlodarczak A,
van der Schaaf RJ,
Torzewski J,
Ferdinande B,
Escaned J,
Iglesias JF,
Bennett J,
Toth G,
Joner M,
Toelg R,
Wiemer M,
Olivecrano G,
Vermeersch P,
Garcia-Garcia H,
Waksman R
May 17, 2023 | 10.4244/EIJ-D-23-00326
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023